Concepedia

Author

Stelios Tsigkos

University of Patras

Also Known As

S Tsigkos, Stelios Tsigkos

24

Publications

970

Citations

12

H-Index

12

Concepts

All Affiliations

University of PatrasNational and Kapodistrian University of AthensEvangelismos HospitalEuropean Medicines AgencyFederal Institute for Drugs and Medical Devices
ST

About

Stelios Tsigkos is an author at University of Patras specializing in medicine, viral pathogenesis, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

216

2

Business

1

1

123

3

Immunology

1

1

93

4

Pharmacology

1

1

123

5

Drug Discovery

1

1

123

Stelios Tsigkos

×

9

Publications

742

Citations

9

H-Index

YearCitations

Angiopoietin-2 Causes Inflammation in Vivo by Promoting Vascular Leakage

Fiorentina Roviezzo, Stelios Tsigkos, Mariarosaria Bucci,

Journal of Pharmacology and Experimental Therapeutics

2005

220

Angiopoietin-2 is increased in severe sepsis: Correlation with inflammatory mediators

Stylianos E. Orfanos, Constantinos Glynos, Chariclea Athanasiou,

Critical Care Medicine

2006

212

Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency

Jan Regnström, Franz Koenig, B. Aronsson,

European Journal of Clinical Pharmacology

2009

123

Vascular endothelial growth factor–mediated induction of angiogenesis by human rhinoviruses

Stelios Psarras, Eleni Volonaki, Chrysanthi Skevaki,

Journal of Allergy and Clinical Immunology

2006

93

Regulation of Ang2 release by PTEN/PI3‐kinase/Akt in lung microvascular endothelial cells

Stelios Tsigkos, Zongmin Zhou, David Fulton,

Journal of Cellular Physiology

2006

28

An Atypical Presentation of Visceral Leishmaniasis Infection in a Patient With Rheumatoid Arthritis Treated With Infliximab

K. Kritikos, Evangelos Haritatos, Stelios Tsigkos,

JCR Journal of Clinical Rheumatology

2009

23

Anti‐angiogenic properties of a sulindac analogue

Anastasia Pyriochou, Stelios Tsigkos, T. P. Vassilakopoulos,

British Journal of Pharmacology

2007

21

Use of biomarkers in the context of orphan medicines designation in the European Union

Stelios Tsigkos, Jordi Llinares, Segundo Mariz,

Orphanet Journal of Rare Diseases

2014

12

Establishing medical plausibility in the context of orphan medicines designation in the European Union

Stelios Tsigkos, Segundo Mariz, Jordi Llinares,

Orphanet Journal of Rare Diseases

2014

10

Page 1